Baclofen for Alcohol Craving Reduction

Dosing Recommendations

• The standard dosing range is 30-80 mg/day according to French guidelines, with 80 mg/day being the maximum recommended dose with marketing authorization 1
• For patients with severe liver disease, a more gradual dose titration is recommended, though baclofen is generally considered safe in patients with liver cirrhosis 1, 2

Clinical Efficacy in Reducing Alcohol Craving

• Baclofen has been shown to decrease alcohol intake and promote abstinence in alcohol-dependent patients 3

Advantages in Patients with Liver Disease

• Baclofen is considered safe in patients with alcoholic liver disease and cirrhosis, unlike naltrexone, which can cause hepatocellular injury 3, 4
• A randomized clinical trial demonstrated the safety and efficacy of baclofen in promoting alcohol abstinence in patients with alcoholic liver disease and cirrhosis 2

Clinical Considerations

• Baclofen has shown efficacy in reducing withdrawal symptoms in addition to craving 2
• Baclofen should be used as part of a comprehensive treatment approach that includes psychosocial interventions 2
• Baclofen should not be discontinued abruptly due to potential withdrawal symptoms 2

Baclofen for Alcohol Abstinence After First-Line Treatment Failure

Primary Indication and Rationale

• The European Association for the Study of the Liver (EASL) guidelines state that baclofen is safe and effective in preventing alcohol relapse in patients with advanced alcoholic liver disease, whereas traditional first-line agents like naltrexone and acamprosate cannot be recommended due to potential hepatotoxicity or lack of safety data in this population 5, 6

Clinical Efficacy

• Baclofen can be used initially for alcohol withdrawal syndrome management and then continued for relapse prevention, providing a dual benefit in the treatment of alcohol-dependent patients 6

Evidence Quality Considerations

• The European Association for the Study of the Liver (EASL) grades the recommendation for baclofen in advanced liver disease as B2, indicating moderate quality evidence 5
• The EASL guidelines explicitly state that baclofen is safe and effective to prevent alcohol relapse in patients with advanced alcoholic liver disease, with a consistent safety profile in liver disease 5, 6